Dr. Bernie Eigl is a distinguished medical oncologist with a focus on genitourinary cancers, particularly prostate and bladder cancers. He completed his medical degree at McMaster University, followed by oncology training and a genitourinary fellowship at BC Cancer.
Dr. Eigl holds several key leadership roles at BC Cancer and the University of British Columbia. He serves as the Provincial Director of Systemic Therapy Clinical Trials, Founding Director of the Provincial Clinical Trials Office, and Deputy Head of the Department of Clinical Research at BC Cancer. In these roles, he is dedicated to expanding clinical trial capacity and infrastructure across all six BC Cancer centres, helping ensure broader access to innovative cancer therapies for patients throughout British Columbia.
Dr. Eigl’s research focuses on advancing genitourinary oncology through innovative clinical trials and biomarker-driven approaches, with a particular emphasis on bladder cancer. He leads several clinical trials exploring novel therapies, including antisense oligonucleotides and oncolytic viruses. Actively engaged in national and international oncology research networks, Dr. Eigl contributes to shaping the future of genitourinary cancer care.
His overarching goal is to improve patient outcomes through personalized treatment strategies informed by biomarker research. Through his leadership and scientific contributions, Dr. Eigl continues to influence clinical practice and drive progress toward more effective, individualized therapies for cancer patients worldwide.
Recent Publications